June 26, 2025
MS-DETECT enrollment completed
We are pleased to announce the completion of enrollment in MS-DETECT (NCT05816122), an international study supported by Sanofi.
This study evaluates MSCopilot® Detect, our digital medical device, designed to detect subtle signs of disability worsening related to multiple sclerosis (MS).
336 patients were enrolled across more than 35 centers in 7 countries: United States, Canada, France, Germany, Spain, Italy, and Denmark.
Initial results are expected in Q3 2027.
An initial presentation of interim data may be presented at ECTRIMS 2025.